Inhaled nitric oxide (iNO) therapy is used in neonatal care as a selective pulmonary vasodilator to improve oxygenation and reduce pulmonary vascular resistance. In preterm infants, the application of ...
GARDEN CITY, N.Y., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the ...
GARDEN CITY, N.Y., July 31, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on ...
Researchers have posted the results of a multisystem phase II clinical trial of patients with COVID-19 and respiratory failure Patients who received inhaled nitric oxide had improved blood oxygen ...
Acute respiratory distress syndrome, or ARDS, is a condition that most commonly occurs in the setting of a lung infection such as COVID-19. “In ARDS, the barrier between the blood vessels and air sacs ...
NEW YORK (Reuters Health) - Infants born prematurely at very low birth weights who are treated with inhaled nitric oxide in the neonatal intensive care unit are significantly less likely to need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results